REFERENCES
1. Yeh MW, Ituarte PHG, Zhou HC, Nishimoto S, Liu I-LA, Harari A, et al.
Incidence and prevalence of primary hyperparathyroidism in a racially
mixed population. J Clin Endocrinol Metab. 2013 Mar;98(3):1122–9.
2. Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the
diagnosis and treatment of primary hyperparathyroidism from 1995 to
2003. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck
Surg. 2005 Mar;132(3):359–72.
3. Day KM, Elsayed M, Monchik JM. No Need to Abandon Focused Unilateral
Exploration for Primary Hyperparathyroidism with Intraoperative
Monitoring of Intact Parathyroid Hormone. J Am Coll Surg. 2015
Aug;221(2):518–23.
4. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive
parathyroidectomy based on 1650 consecutive patients with primary
hyperparathyroidism. Ann Surg. 2011 Mar;253(3):585–91.
5. Carneiro-Pla DM, Solorzano CC, Irvin GL. Consequences of targeted
parathyroidectomy guided by localization studies without intraoperative
parathyroid hormone monitoring. J Am Coll Surg. 2006 May;202(5):715–22.
6. Bachar G, Mizrachi A, Hadar T, Feinmesser R, Shpitzer T. Role of
parathyroid hormone monitoring during parathyroidectomy. Head Neck. 2011
Dec;33(12):1754–7.
7. Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI,
Moore FD. Reassessment of parathyroid hormone monitoring during
parathyroidectomy for primary hyperparathyroidism after 2 preoperative
localization studies. Arch Surg Chic Ill 1960. 2006 Apr;141(4):381–4;
discussion 384.
8. Grant CS, Thompson G, Farley D, van Heerden J. Primary
hyperparathyroidism surgical management since the introduction of
minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg
Chic Ill 1960. 2005 May;140(5):472–8; discussion 478-479.
9. Levy JM, Kandil E, Yau LC, Cuda JD, Sheth SN, Tufano RP. Can
ultrasound be used as the primary screening modality for the
localization of parathyroid disease prior to surgery for primary
hyperparathyroidism? A review of 440 cases. ORL J Oto-Rhino-Laryngol Its
Relat Spec. 2011;73(2):116–20.
10. Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P.
Ultrasonography in detection of single and multiple abnormal parathyroid
glands in primary hyperparathyroidism: comparison with radionuclide
scintigraphy and surgery. Clin Endocrinol (Oxf). 2006 Sep;65(3):340–5.
11. Stern S, Tzelnick S, Mizrachi A, Cohen M, Shpitzer T, Bachar G.
Accuracy of Neck Ultrasonography in Predicting the Size and Location of
Parathyroid Adenomas. Otolaryngol–Head Neck Surg Off J Am Acad
Otolaryngol-Head Neck Surg. 2018 Dec;159(6):968–72.
12. Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS. Confirmation of
Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques? J
Surg Res. 2020 Feb;246:139–44.
13. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R,
Marcocci C, et al. Guidelines for the management of asymptomatic primary
hyperparathyroidism: summary statement from the Fourth International
Workshop. J Clin Endocrinol Metab. 2014 Oct;99(10):3561–9.
14. Riss P, Scheuba C, Asari R, Bieglmayer C, Niederle B. Is minimally
invasive parathyroidectomy without QPTH monitoring justified?
Langenbecks Arch Surg. 2009 Sep;394(5):875–80.
15. Bergenfelz AOJ, Hellman P, Harrison B, Sitges-Serra A, Dralle H,
European Society of Endocrine Surgeons. Positional statement of the
European Society of Endocrine Surgeons (ESES) on modern techniques in
pHPT surgery. Langenbecks Arch Surg. 2009 Sep;394(5):761–4.
16. Helbrow J, Owais AE, Sidwell AG, Frank LM, Lucarotti ME. The use of
intraoperative parathyroid hormone monitoring in minimally invasive
parathyroid surgery. Ann R Coll Surg Engl. 2016 Sep;98(7):516–9.
17. Sartori PV, Saibene AM, Leopaldi E, Boniardi M, Beretta E, Colombo
S, et al. Intraoperative parathyroid hormone testing in primary
hyperparathyroidism surgery: time for giving up? Eur Arch
Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger
Soc Oto-Rhino-Laryngol - Head Neck Surg. 2019 Jan;276(1):267–72.
18. Suliburk JW, Sywak MS, Sidhu SB, Delbridge LW. 1000 minimally
invasive parathyroidectomies without intra-operative parathyroid hormone
measurement: lessons learned. ANZ J Surg. 2011 May;81(5):362–5.
19. Najafian A, Kahan S, Olson MT, Tufano RP, Zeiger MA. Intraoperative
PTH May Not Be Necessary in the Management of Primary
Hyperparathyroidism Even with Only One Positive or Only Indeterminate
Preoperative Localization Studies. World J Surg. 2017 Jun;41(6):1500–5.
20. Nair CG, Babu MJC, Jacob P, Menon R, Mathew J. Is intraoperative
parathyroid hormone monitoring necessary in symptomatic primary
hyperparathyroidism with concordant imaging? Indian J Endocrinol Metab.
2016 Aug;20(4):512–6.
21. Norman J, Lopez J, Politz D. Abandoning unilateral
parathyroidectomy: why we reversed our position after 15,000 parathyroid
operations. J Am Coll Surg. 2012 Mar;214(3):260–9.
22. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL. Comparison
of intraoperative iPTH assay (QPTH) criteria in guiding
parathyroidectomy: which criterion is the most accurate? Surgery. 2003
Dec;134(6):973–9; discussion 979-981.
23. Morris LF, Zanocco K, Ituarte PHG, Ro K, Duh Q-Y, Sturgeon C, et al.
The value of intraoperative parathyroid hormone monitoring in localized
primary hyperparathyroidism: a cost analysis. Ann Surg Oncol. 2010
Mar;17(3):679–85.
24. Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA. Would scan, but
which scan? A cost-utility analysis to optimize preoperative imaging for
primary hyperparathyroidism. Surgery. 2011 Dec;150(6):1286–94.
25. Badii B, Staderini F, Foppa C, Tofani L, Skalamera I, Fiorenza G, et
al. Cost-benefit analysis of the intraoperative parathyroid hormone
assay in primary hyperparathyroidism. Head Neck. 2017 Feb;39(2):241–6.